|
Sep 12
|
UPDATE 1-Timeline for supply limits on Novo Nordisk weight-loss drug unclear, US FDA says
|
|
Sep 12
|
Wall Street Has Found Its Next High-Flying Stock-Split Stock. Here's Why I'm Not Buying the Hype.
|
|
Sep 12
|
The Zacks Analyst Blog Highlights Microsoft, Novo Nordisk, Booking Holdings, Sony and EOG
|
|
Sep 11
|
Top Stock Reports for Microsoft, Novo Nordisk & Booking Holdings
|
|
Sep 11
|
Take the Zacks Approach to Beat the Market: Shopify, Novo Nordisk, Amgen in Focus
|
|
Sep 10
|
Investors May Not Have Seen the Best From Eli Lilly Stock Yet. Here's Why.
|
|
Sep 9
|
10 Biotech Stocks with Biggest Upside
|
|
Sep 9
|
3 Top Healthcare Stocks to Buy for September
|
|
Sep 8
|
Novo Nordisk (NVO) Gains But Lags Market: What You Should Know
|
|
Sep 8
|
Ozempic, Wegovy could help type 1 diabetics: Study
|
|
Sep 8
|
1 Stock Split Stock to Buy Hand Over Fist Right Now
|
|
Sep 8
|
Lars Fruergaard Jørgensen, the Novo Nordisk boss who dethroned Europe’s biggest company
|
|
Sep 8
|
25 Most Health-Conscious Cities in the US
|
|
Sep 7
|
Why Novo Nordisk Stock Topped the Market on Thursday
|
|
Sep 7
|
Unveiling Novo Nordisk A/S (NVO)'s Value: Is It Really Priced Right? A Comprehensive Guide
|
|
Sep 7
|
Weight-Loss Drug Market Can Hit $100 Billion, J.P. Morgan Says. That Makes Eli Lilly Stock a Big Winner.
|
|
Sep 7
|
Is Novo Nordisk Stock a Buy Now?
|
|
Sep 6
|
How Novo Nordisk became Europe's most valuable company
|
|
Sep 5
|
Novo Nordisk (NVO) Launches Wegovy in UK Amid Supply Issues
|
|
Sep 5
|
Novo Nordisk Becomes Europe's Most Valuable Company as Wegovy Launches in UK
|